KaruT.2010. Mitochondrial mechanisms of photobiomodulation in context of new data about multiple roles of ATP. Photomed. Laser Surg., 28:159–160.
2.
LanzafameR.J.2011. Photobiomodulation and cancer and other musings. Photomed. Laser Surg., 29:3–4.
3.
Santana–BlankL.2004. Contraindications in noninvasive laser therapy: truth and fiction. Photomed. Laser Surg., 22:442.
4.
Santana–BlankL.A., Rodríguez–SantanaE., VargasF.et al.2002. Phase I trial of an infrared pulsed laser device in patients with advanced neoplasias. Clin. Cancer Res., 8:3082–3091.
5.
ZiminA.A., ZhevagoN.A., BuĭniakovaA.I., SamoĭlovaK.A.2009. Application of low-power visible and near infrared radiation in clinical oncology.Vopr. Kurortol. Fizioter. Lech. Fiz. Kult., 6:49–52.
6.
TataD.B., FaheyM., MitraK., AndersJ., WaynantR.W.2007. Near-IR induced suppression of metabolic activity in aggressive cancers. Proc. SPIE, 6428:64280E.
7.
TataD.B., WaynantR.W.2008. Laser light induced modulations in metabolic activities in human brain cancer. Proc. SPIE, 6846:684607.
8.
WangF., ChenT.S., XingD., WangJ.J., WuY.X.2005. Measuring dynamics of caspase-3 activity in living cells using FRET technique during apoptosis induced by high fluence low-power laser irradiation. Lasers Surg. Med., 36:2–7.
9.
Myakishev–RempelM., StadlerI., BrondonP., AxeD.R., FriedmanM., NardiaF.B., LanzafameR.2012. A preliminary study of the safety of red light phototherapy of tissues harboring cancer. Photomed. Laser Surg., 30:551–558.
10.
Santana–BlankL.A., ReyesH., Rodríguez–SantanaE., Santana–RodríguezK.E.2004. Microdensitometry of T2-weighted magnetic resonance (MR) images from patients with advanced neoplasias in a phase I clinical trial of an infrared pulsed laser device (IPLD)Lasers Surg. Med., 34:398–406.
11.
Santana–BlankL.A., CastesM., RojasM.E., VargasF., Scott–AlgaraD.1992. Evaluation of serum levels of tumour necrosis factor-alpha (TNF-alpha) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment. Clin. Exp. Immunol., 90:43–48.
12.
Santana–BlankL.A., Rodríguez–SantanaE., VargasF., Santana–RodríguezK.E.2002. Photo-induced cytomorphologic changes in an advanced cancer phase I clinical trial. Lasers Surg. Med., 30:18–25.
13.
PrendergastG.C.2011. Perspectives on emerging trends in cancer research. Cancer Res., 71:2027–2028.
14.
Santana–BlankL., Rodríguez–SantanaE., Santana–RodríguezK.E.2011. Cancer, Warburg effect and laser photobiomodulation – progress beyond skepticism. Journal of Chinese Clinical Medicine., 6:147–157.
15.
SzijgyartoZ., GaredewA., AzevedoC., SaiardiA.2011. Influence of inositol pyrophosphates on cellular energy dynamics. Science, 334:802–805.
16.
SaiardiA.2012. How inositol pyrophosphates control cellular phosphate homeostasis?Adv Biol Regul., 52:351–359.
17.
AranyP.R.2012. Photobiomodulation: poised from the fringes. Photomed. Laser Surg., 30:507–509.
18.
Santana–BlankL.2003. Modulated low-energy near-infrared (NIR) lasers and cancer: An invitation to discuss a new treatment approach. Lasers Surg. Med., 32:1–2.
